Biomerica (NASDAQ:BMRA) Announces Quarterly Earnings Results

Biomerica (NASDAQ:BMRA) issued its quarterly earnings data on Friday. The company reported ($0.11) earnings per share (EPS) for the quarter, reports. The firm had revenue of $1.02 million for the quarter. Biomerica had a negative return on equity of 64.25% and a negative net margin of 110.58%.

Biomerica Stock Up 2.0 %

NASDAQ BMRA opened at $0.83 on Monday. Biomerica has a fifty-two week low of $0.70 and a fifty-two week high of $2.13. The stock has a market cap of $13.93 million, a price-to-earnings ratio of -2.24 and a beta of -1.04. The business has a fifty day moving average of $1.00 and a 200-day moving average of $0.97.

Hedge Funds Weigh In On Biomerica

A number of institutional investors have recently made changes to their positions in BMRA. Potomac Capital Management Inc. acquired a new position in shares of Biomerica in the first quarter worth $808,000. Point72 Asset Management L.P. acquired a new position in shares of Biomerica in the fourth quarter worth $1,407,000. Wasatch Advisors LP raised its holdings in shares of Biomerica by 69.6% in the first quarter. Wasatch Advisors LP now owns 974,973 shares of the company’s stock worth $1,823,000 after acquiring an additional 400,000 shares during the last quarter. Boothbay Fund Management LLC acquired a new position in shares of Biomerica in the first quarter worth $481,000. Finally, Vanguard Group Inc. raised its holdings in shares of Biomerica by 7.6% in the fourth quarter. Vanguard Group Inc. now owns 609,365 shares of the company’s stock worth $762,000 after acquiring an additional 42,833 shares during the last quarter. 22.28% of the stock is owned by institutional investors and hedge funds.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.